S&P 500   5,138.29 (+0.02%)
DOW   39,061.92 (-0.07%)
QQQ   445.01 (-0.13%)
AAPL   174.20 (-3.04%)
MSFT   416.19 (+0.17%)
META   502.63 (+0.07%)
GOOGL   132.82 (-3.15%)
AMZN   178.43 (+0.12%)
TSLA   188.00 (-7.22%)
NVDA   860.75 (+4.61%)
NIO   5.35 (-7.44%)
AMD   206.69 (+2.00%)
BABA   71.98 (-3.54%)
T   16.86 (-0.71%)
F   12.85 (+3.21%)
MU   96.66 (+1.59%)
CGC   3.00 (-6.54%)
GE   160.75 (+1.32%)
DIS   113.12 (+1.05%)
AMC   4.26 (-2.29%)
PFE   25.96 (-2.37%)
PYPL   59.52 (-1.68%)
XOM   104.30 (-1.46%)
S&P 500   5,138.29 (+0.02%)
DOW   39,061.92 (-0.07%)
QQQ   445.01 (-0.13%)
AAPL   174.20 (-3.04%)
MSFT   416.19 (+0.17%)
META   502.63 (+0.07%)
GOOGL   132.82 (-3.15%)
AMZN   178.43 (+0.12%)
TSLA   188.00 (-7.22%)
NVDA   860.75 (+4.61%)
NIO   5.35 (-7.44%)
AMD   206.69 (+2.00%)
BABA   71.98 (-3.54%)
T   16.86 (-0.71%)
F   12.85 (+3.21%)
MU   96.66 (+1.59%)
CGC   3.00 (-6.54%)
GE   160.75 (+1.32%)
DIS   113.12 (+1.05%)
AMC   4.26 (-2.29%)
PFE   25.96 (-2.37%)
PYPL   59.52 (-1.68%)
XOM   104.30 (-1.46%)
S&P 500   5,138.29 (+0.02%)
DOW   39,061.92 (-0.07%)
QQQ   445.01 (-0.13%)
AAPL   174.20 (-3.04%)
MSFT   416.19 (+0.17%)
META   502.63 (+0.07%)
GOOGL   132.82 (-3.15%)
AMZN   178.43 (+0.12%)
TSLA   188.00 (-7.22%)
NVDA   860.75 (+4.61%)
NIO   5.35 (-7.44%)
AMD   206.69 (+2.00%)
BABA   71.98 (-3.54%)
T   16.86 (-0.71%)
F   12.85 (+3.21%)
MU   96.66 (+1.59%)
CGC   3.00 (-6.54%)
GE   160.75 (+1.32%)
DIS   113.12 (+1.05%)
AMC   4.26 (-2.29%)
PFE   25.96 (-2.37%)
PYPL   59.52 (-1.68%)
XOM   104.30 (-1.46%)
S&P 500   5,138.29 (+0.02%)
DOW   39,061.92 (-0.07%)
QQQ   445.01 (-0.13%)
AAPL   174.20 (-3.04%)
MSFT   416.19 (+0.17%)
META   502.63 (+0.07%)
GOOGL   132.82 (-3.15%)
AMZN   178.43 (+0.12%)
TSLA   188.00 (-7.22%)
NVDA   860.75 (+4.61%)
NIO   5.35 (-7.44%)
AMD   206.69 (+2.00%)
BABA   71.98 (-3.54%)
T   16.86 (-0.71%)
F   12.85 (+3.21%)
MU   96.66 (+1.59%)
CGC   3.00 (-6.54%)
GE   160.75 (+1.32%)
DIS   113.12 (+1.05%)
AMC   4.26 (-2.29%)
PFE   25.96 (-2.37%)
PYPL   59.52 (-1.68%)
XOM   104.30 (-1.46%)
NASDAQ:TRNS

Transcat (TRNS) Stock Price, News & Analysis

$105.61
+0.09 (+0.09%)
(As of 12:43 PM ET)
Today's Range
$104.41
$107.42
50-Day Range
$95.96
$112.89
52-Week Range
$74.89
$115.41
Volume
18,249 shs
Average Volume
36,300 shs
Market Capitalization
$932.54 million
P/E Ratio
81.24
Dividend Yield
N/A
Price Target
$114.00

Transcat MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
8.1% Upside
$114.00 Price Target
Short Interest
Healthy
2.08% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.30mentions of Transcat in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$635,600 Sold Last Quarter
Proj. Earnings Growth
54.41%
From $1.36 to $2.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.06 out of 5 stars

Computer And Technology Sector

309th out of 595 stocks

Instruments To Measure Electricity Industry

5th out of 8 stocks


TRNS stock logo

About Transcat Stock (NASDAQ:TRNS)

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

TRNS Stock Price History

TRNS Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Craig-Hallum Keeps Their Buy Rating on Transcat (TRNS)
Reasons for the Outperformance of Transcat (TRNS)
VSE Aviation Bags Contracts Worth $750 Mln
Transcat: Might Be The Right Time To Exit
See More Headlines
Receive TRNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transcat and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/29/2024
Today
3/04/2024
Fiscal Year End
3/31/2024
Next Earnings (Estimated)
5/27/2024

Industry, Sector and Symbol

Industry
Instruments to measure electricity
Sub-Industry
N/A
Current Symbol
NASDAQ:TRNS
Employees
1,030
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$114.00
High Stock Price Target
$124.00
Low Stock Price Target
$110.00
Potential Upside/Downside
+8.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$10.69 million
Pretax Margin
5.45%

Debt

Sales & Book Value

Annual Sales
$230.57 million
Cash Flow
$2.86 per share
Book Value
$24.74 per share

Miscellaneous

Free Float
8,458,000
Market Cap
$931.74 million
Optionable
Not Optionable
Beta
0.59
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report














TRNS Stock Analysis - Frequently Asked Questions

Should I buy or sell Transcat stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TRNS shares.
View TRNS analyst ratings
or view top-rated stocks.

What is Transcat's stock price target for 2024?

2 Wall Street analysts have issued 1-year target prices for Transcat's shares. Their TRNS share price targets range from $110.00 to $124.00. On average, they anticipate the company's share price to reach $114.00 in the next year. This suggests a possible upside of 8.1% from the stock's current price.
View analysts price targets for TRNS
or view top-rated stocks among Wall Street analysts.

How have TRNS shares performed in 2024?

Transcat's stock was trading at $109.33 at the beginning of 2024. Since then, TRNS stock has decreased by 3.6% and is now trading at $105.43.
View the best growth stocks for 2024 here
.

When is Transcat's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our TRNS earnings forecast
.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) issued its quarterly earnings data on Monday, January, 29th. The scientific and technical instruments company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The scientific and technical instruments company had revenue of $65.17 million for the quarter, compared to analysts' expectations of $63.36 million. Transcat had a net margin of 4.16% and a trailing twelve-month return on equity of 9.32%.

What ETFs hold Transcat's stock?

ETFs with the largest weight of Transcat (NASDAQ:TRNS) stock in their portfolio include Invesco DWA SmallCap Momentum ETF (DWAS).AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC).

What is Lee Rudow's approval rating as Transcat's CEO?

20 employees have rated Transcat Chief Executive Officer Lee Rudow on Glassdoor.com. Lee Rudow has an approval rating of 69% among the company's employees.

What other stocks do shareholders of Transcat own?
Who are Transcat's major shareholders?

Transcat's stock is owned by a number of retail and institutional investors. Top institutional investors include Neuberger Berman Group LLC (8.91%), Conestoga Capital Advisors LLC (8.64%), Wasatch Advisors LP (7.94%), Vanguard Group Inc. (5.41%), Broadcrest Asset Management LLC (4.53%) and Northern Trust Corp (0.97%). Insiders that own company stock include Carl E Sassano, Charles P Hadeed, Craig D Cairns, Gary J Haseley, James M Jenkins, Lee D Rudow, Lee D Rudow, Michael W West, Richard J Harrison and Scott Deverell.
View institutional ownership trends
.

How do I buy shares of Transcat?

Shares of TRNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TRNS) was last updated on 3/4/2024 by MarketBeat.com Staff